Sofosbuvir 400 mg Tablets are an important direct-acting antiviral (DAA) medicine used as part of combination treatment for chronic hepatitis C virus (HCV) infection. Sofosbuvir works by inhibiting the HCV NS5B polymerase, an enzyme required for viral replication. Because hepatitis C treatment depends on the patient's HCV genotype, liver condition, previous treatment history, and other medicines, Sofosbuvir should be used only according to a healthcare professional's prescribed treatment regimen.
What Are Sofosbuvir 400 mg Tablets Used For?
Sofosbuvir 400 mg is used in combination with other antiviral medicines for the treatment of chronic hepatitis C. Current U.S. prescribing information includes adults with HCV genotypes 1, 2, 3, or 4 who do not have cirrhosis or who have compensated cirrhosis. Pediatric indications also exist for certain patients and treatment combinations.
Sofosbuvir is not generally intended to be used alone for hepatitis C treatment. The appropriate combination and treatment duration depend on factors such as HCV genotype, cirrhosis status, previous treatment, and the other medicines selected by the healthcare provider.
How Does Sofosbuvir Work?
Sofosbuvir is a nucleotide analog inhibitor of the HCV NS5B RNA-dependent RNA polymerase. After conversion to its active form inside the body, it interferes with viral RNA replication. This helps suppress HCV replication during antiviral treatment.
The 400 mg strength is commonly administered as one tablet once daily in approved treatment regimens. The tablet may be taken with or without food, but patients should follow the exact regimen prescribed for their condition.
Important Safety Information
Before starting Sofosbuvir 400 mg treatment, patients should inform their healthcare professional about all medicines, supplements, and medical conditions. A particularly important safety consideration is hepatitis B virus (HBV) infection.
The FDA prescribing information carries a boxed warning regarding the risk of HBV reactivation in patients who are also infected with hepatitis B. HBV reactivation can cause serious liver complications, including liver failure and, in some cases, death. Patients should therefore be evaluated for current or previous HBV infection before beginning HCV antiviral therapy.
Drug interactions should also be reviewed before treatment. Certain medicines can affect sofosbuvir-containing treatment or may require special monitoring. Patients should not start, stop, or change prescription or non-prescription medicines without consulting their healthcare professional.
Possible Side Effects
The side effects experienced during Sofosbuvir treatment can depend on the complete antiviral regimen being used. When Sofosbuvir is combined with other medicines, some reported adverse reactions may be associated with the combination rather than Sofosbuvir alone.
Patients should contact their healthcare provider if they experience unusual or persistent symptoms during treatment. Serious or unexpected reactions require prompt medical attention.
Who Should Take Sofosbuvir 400 mg?
Sofosbuvir 400 mg should be prescribed based on an individual's HCV diagnosis and clinical condition. Healthcare professionals may consider HCV genotype, presence or absence of cirrhosis, previous hepatitis C treatment, kidney and liver status, pregnancy considerations where relevant, and potential drug interactions before selecting a treatment regimen.
Because treatment recommendations can change as approved therapies and clinical guidelines are updated, patients should rely on current prescribing information and professional medical advice rather than using an older treatment schedule found online.
Sofosbuvir 400 mg Tablets: Key Points
Sofosbuvir 400 mg is an established direct-acting antiviral used as part of combination therapy for chronic hepatitis C. It works by targeting the HCV NS5B polymerase and reducing viral replication. The medicine must be used according to the prescribed combination and duration.
For patients and healthcare professionals, important considerations include checking for hepatitis B infection, reviewing potential drug interactions, following the prescribed dose, and completing the recommended treatment course.
Frequently Asked Questions
What is Sofosbuvir 400 mg used for?
Sofosbuvir 400 mg is used with other antiviral medicines to treat chronic hepatitis C infection in appropriate patients.
Can Sofosbuvir 400 mg be taken alone?
Sofosbuvir should not be used as monotherapy for chronic hepatitis C. The appropriate combination treatment should be selected by a qualified healthcare professional.
How often is Sofosbuvir 400 mg taken?
In approved regimens, the recommended dose of Sovaldi is one 400 mg tablet once daily, with or without food. The complete regimen and duration depend on the patient's clinical circumstances.
Is Sofosbuvir effective for every type of hepatitis C?
Treatment suitability varies by HCV genotype and patient characteristics. Current labeling includes specific indications for genotypes 1–4, while other sofosbuvir-containing combinations are used for broader genotype coverage.
What is the most important safety warning?
One of the most important warnings is the possibility of hepatitis B reactivation in patients with current or previous HBV infection. Appropriate screening and monitoring are recommended before and during HCV treatment.
Medical Disclaimer: This article is intended for general educational and informational purposes and does not replace advice from a qualified healthcare professional. Sofosbuvir 400 mg should be used only under appropriate medical supervision and according to the applicable prescribing information in the patient's country.